Biotech research

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Edwards Lifesciences Corp (NYSE:EW) Reports Positive Outcome From Self-Expanding CENTERA Valve Clinical Trials

Pieris Pharmaceuticals Inc (NASDAQ:PIRS Strikes A $45 million Deal With AstraZeneca plc (ADR)(NYSE:AZN)

Allergan plc Ordinary Shares (NYSE:AGN) Outlines $10 Billion Buyback Program after Pfizer Inc. (NYSE:PFE) Merger Blow

Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Hit Setback In Pain Study

Here’s What’s Moving Agenus Inc (NASDAQ:AGEN) and Cerus Corporation (NASDAQ:CERS)

Weekly Biotech Report Covering – Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Immunomedics Inc...

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Has More Upside Potential, Even After Gains

Inside The FDA: Why Cempra Inc (NASDAQ:CEMP) Solithromycin Yes Vote Isn’t...

What We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)...

Roche Just Picked Up A Range Of Potential Billion Dollar Indications

Does Novartis AG (NYSE:NVS) Have The Solution For Malaria?

Novartis AG (NYSE:NVS) Announces Positive Phase III Results For MS Drug

Why Even After 150% Move In PhaseRx Inc. (NASDAQ:PZRX), Shares Are...

Biotech Movers and Shakers: Aclaris Therapeutics Inc (NASDAQ:ACRS) and XenoPort, Inc....

Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK), And Other...

EDITOR PICKS

Xenon Pharmaceuticals (XENE) Just Took A Hit: Here’s Why And What’s...

Here’s Why These Two Biotechnology Companies Took A Hit On Monday:...

Here’s What Just Happened With Portola Pharmaceuticals Inc (NASDAQ:PTLA) and bluebird...

POPULAR POSTS

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY